evidencegaps
Primary study · included by 1 review

A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.

Patel 2023 · Patel Shetal A, Gibson Michael K, Deal Allison, et al. · Cancer · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Patel 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.